Acorda Therapeutics, Inc. Payments for Restructuring
Acorda Therapeutics, Inc. reported Payments for Restructuring of $2.10 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2024-04-01
- Acorda Therapeutics, Inc. payments for restructuring for the quarter ending 2022-09-30 was $257.00K, a 70.86% decline year-over-year.
- Acorda Therapeutics, Inc. payments for restructuring for the quarter ending 2022-06-30 was $145.00K, a 13.28% increase year-over-year.
- Acorda Therapeutics, Inc. payments for restructuring for the quarter ending 2022-03-31 was $1.70M, a 10.10% decline year-over-year.
- Acorda Therapeutics, Inc. payments for restructuring for the quarter ending 2021-09-30 was $882.00K.
- Acorda Therapeutics, Inc. payments for restructuring for fiscal 2022 was $2.10M, a 49.34% decline from fiscal 2021.
- Acorda Therapeutics, Inc. payments for restructuring for fiscal 2021 was $4.15M, a 158.18% increase from fiscal 2020.
- Acorda Therapeutics, Inc. payments for restructuring for fiscal 2020 was $1.61M, a 48.77% decline from fiscal 2019.
- Acorda Therapeutics, Inc. payments for restructuring for fiscal 2019 was $3.14M, a 72.36% increase from fiscal 2018.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2022-12-31 | $2.10M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $257.00K 10-Q · filed 2022-11-14 | $402.00K derived: sum of 2 quarters · filed 2022-11-14 | $2.10M derived: sum of 3 quarters · filed 2022-11-14 | |
| 2022-06-30 | $145.00K 10-Q · filed 2022-11-14 | $1.84M derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2022-03-31 | $1.70M 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | $4.15M 10-K · filed 2023-03-15 | |||
| 2021-09-30 | $882.00K 10-Q · filed 2021-11-12 | $1.01M derived: sum of 2 quarters · filed 2021-11-12 | $2.90M derived: sum of 3 quarters · filed 2021-11-12 | |
| 2021-06-30 | $128.00K 10-Q · filed 2021-11-12 | $2.02M derived: sum of 2 quarters · filed 2021-11-12 | ||
| 2021-03-31 | $1.89M 10-Q · filed 2021-11-12 | |||
| 2020-12-31 | $1.61M 10-K · filed 2022-03-18 | |||
| 2019-12-31 | $3.14M 10-K · filed 2021-03-16 | |||
| 2018-12-31 | $1.82M 10-K · filed 2020-02-28 | |||
| 2017-12-31 | $438.00K 10-K/A · filed 2018-03-09 | $901.00K derived: sum of 2 quarters · filed 2018-03-09 | $7.14M derived: sum of 3 quarters · filed 2018-03-09 | $7.14M 10-K · filed 2019-02-27 |
| 2017-09-30 | $463.00K 10-K/A · filed 2018-03-09 | $6.70M derived: sum of 2 quarters · filed 2018-03-09 | ||
| 2017-06-30 | $6.24M 10-K/A · filed 2018-03-09 | $6.24M 10-Q · filed 2017-08-08 |